The role of changes in systemic inflammatory response markers during neoadjuvant chemotherapy in predicting suboptimal surgery in ovarian cancer

Gulseren, VAROL; Cakir, Ilker; Ozdemir, Isa; Sanci, Muzaffer; Gokcu, Mehmet; Gungorduk, Kemal

doi:10.1016/j.currproblcancer.2020.100536

The role of changes in systemic inflammatory response markers during neoadjuvant chemotherapy in predicting suboptimal surgery in ovarian cancer

Copy For Citation

Gulseren V., Cakir I., Ozdemir I. A., Sanci M., Gokcu M., Gungorduk K.

CURRENT PROBLEMS IN CANCER, vol.44, no.4, 2020 (SCI-Expanded)

Publication Type: Article / Article
Volume: 44 Issue: 4
Publication Date: 2020
Doi Number: 10.1016/j.currproblcancer.2020.100536
Journal Name: CURRENT PROBLEMS IN CANCER
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, MEDLINE
Erciyes University Affiliated: Yes

Abstract

Aim: The aim of this study was to investigate the possibility of using the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio, and platelet count and their dynamic changes during chemotherapy to predict suboptimal interval debulking surgery (IDS) in stage IIIC-IVA serous ovarian cancer (OC).